Linden Advisors’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-192,734
| Closed | -$2.1K | – | 565 |
|
|
2022
Q4 | $2.1K | Hold |
192,734
| – | – | ﹤0.01% | 558 |
|
|
2022
Q3 | $19K | Hold |
192,734
| – | – | ﹤0.01% | 592 |
|
|
2022
Q2 | $15K | Hold |
192,734
| – | – | ﹤0.01% | 685 |
|
|
2022
Q1 | $35K | Sell |
192,734
-32,265
| -14% | -$5.86K | ﹤0.01% | 688 |
|
|
2021
Q4 | $120K | Hold |
224,999
| – | – | ﹤0.01% | 697 |
|
|
2021
Q3 | $130K | Hold |
224,999
| – | – | ﹤0.01% | 616 |
|
|
2021
Q2 | $169K | Buy |
+224,999
| New | +$169K | ﹤0.01% | 708 |
|